Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Kinnevik AB (publ) (“Kinnevik”) meddelade idag att bolaget har investerat 75 MUSD i VillageMD, en ledande aktör inom primärvård baserad i USA. Kinnevik ledde Serie B-finansieringsrundan om totalt 100...
-
Kinnevik AB (publ) (“Kinnevik”), today announced that it has invested USD 75m in VillageMD, a leading US based provider of primary care and a pioneer in the delivery of value-based care. Kinnevik led...
-
Kinnevik AB (publ) ("Kinnevik") meddelade idag att bolaget kommer att delta med 50 MUSD i en finansieringsrunda på upp till 500 MUSD i Babylon Holdings Limited ("Babylon"), det digitala...
-
Kinnevik AB (publ) (“Kinnevik”), today announced that it will participate with a USD 50m investment in a fundraise of up to USD 500m by Babylon Holdings Limited (“Babylon”), the digital healthcare...
-
Kinnevik AB (publ) ("Kinnevik") har noterat medieuppgifter angående en potentiell finansieringsrunda i Babylon Holdings Limited, ett bolag där Kinnevik för närvarande äger 20 procent. Kinnevik kan...
-
Kinnevik AB (publ) (“Kinnevik”), has noted recent media articles regarding a potential fudraise in Babylon Holdings Limited, where Kinnevik currently has a 20 percent interest. Kinnevik can...
-
Kinnevik AB (publ) ("Kinnevik") meddelade idag att Livongo Health, Inc. ("Livongo") har fastställt det slutliga priset i bolagets börsnotering (”Börsnoteringen”) till 28 USD per aktie, motsvarande en...
-
PRICING OF LIVONGO’S IPO Kinnevik AB (publ) ("Kinnevik") today announced that Livongo Health, Inc. ("Livongo") has set the final price in its initial public offering (the "IPO") at USD 28 per share,...
-
”Det har varit ett händelserikt andra kvartal, under vilket vi har fortsatt arbetet med att vikta om vår portfölj till en större andel tillväxtbolag. Detta har gjorts bland annat genom att stötta...
-
”It was an eventful second quarter, during which we focused our efforts on continuing the shift in our portfolio towards growth companies. These efforts included supporting high-performers in our...